FirstWord Group
banner
firstwordgroup.com
FirstWord Group
@firstwordgroup.com
FirstWord is a global leader in news and intelligence for the Pharma and MedTech industries. Find our services here www.firstwordpharma.com, www.firstwordhealthtech.com, and www.firstwordreports.com
Join this exclusive discussion to learn how to build compelling, ROI-driven business cases for digital health — grounded in both commercial reality and clinical need.

🔗 Register here: us02web.zoom.us/webinar/regi...
September 22, 2025 at 2:43 PM
Join FirstWord for an exclusive discussion spotlighting expert perspectives on evolving treatment pathways, pivotal clinical trials, and key product developments shaping the #obesity market

👉 Register today! us02web.zoom.us/webinar/regi...
September 18, 2025 at 2:41 PM
How Strategic Planning Shapes Successful Cell & Gene Therapy Launches. Learn more here: firstwordpharma.com/navigating-l...

Brought to you by #UnipharGroup

#biopharma #biotechnology #celltherapy #CGTs #druglaunch #genetherapy #pharmaceuticals #rarediseases #regulatoryaffairs
July 16, 2025 at 3:14 PM
2025 has been unpredictable for #biopharma — policy shifts and pricing pressures are reshaping the US market. Join FirstWord Pharma’s editorial team as they unpack key trends and milestones so far and share what to watch for in the months ahead. 👉 us02web.zoom.us/webinar/regi...

Sponsored by RxY
July 7, 2025 at 3:26 PM
Making CGTs Work Worldwide: Key Barriers and Enablers in Global Access and Distribution. Learn more here: firstwordpharma.com/current-cgt-...

Brought to you by #UnipharGroup

#biopharma #biotechnology #celltherapy #CGTs #drugdevelopment #genetherapy #pharmaceuticals #rarediseases #regulatoryaffairs
July 3, 2025 at 3:45 PM
From Rare to Routine: What’s Driving the Next Phase of Cell and Gene Therapy Growth. Learn more here: firstwordpharma.com/current-cgt-...

Brought to you by #UnipharGroup

#biopharma #biotechnology #celltherapy #CGTs #drugdevelopment #genetherapy #pharmaceuticals #rarediseases #regulatoryaffairs
July 1, 2025 at 2:26 PM
📅 Get ahead of the curve in the HS space. Join FirstWord for a live preview of our upcoming KOL Insight report, featuring expert perspectives on evolving treatment pathways, pivotal clinical trials, and key product developments shaping the HS market.

Register 👉 us02web.zoom.us/webinar/regi...
June 23, 2025 at 2:19 PM
There is still time to register! Don’t miss your chance to hear from experts from Pfizer, GSK, and S3 Connected Health on how leading teams are rethinking success in digital health. 🔗 Register here: us02web.zoom.us/webinar/regi...

#biopharma #digitalhealth #healthtech #pharmaceuticals
May 19, 2025 at 5:26 PM
Join experts from Pfizer, GSK, and S3 Connected Health as they explore how to measure real business impact across branded companion products, above-brand solutions, and PDURs. Register here us02web.zoom.us/webinar/regi...

#biopharma #commercialstrategy #digitalhealth #healthtech #medaffairs #pharma
May 13, 2025 at 2:49 PM
Are you measuring #digitalhealth success with downloads and app usage? Learn from experts as they break down frameworks for measuring ROI across branded digital tools, above-brand solutions, and PDURs—and share how to align stakeholders around metrics that matter. us02web.zoom.us/webinar/regi...
April 25, 2025 at 2:02 PM
🚨 Don’t miss your chance to get ahead of the curve — Join us for expert insights into the industry’s fastest-growing drug brands, what’s driving their growth, and what it means for the future of pharma innovation.

Register today! 👉 us02web.zoom.us/webinar/regi...
April 22, 2025 at 12:56 PM
Join industry leaders from UCB, Bristol Myers Squibb, and Astellas as they share real-world strategies for improving cross-functional collaboration in #pharma. Gain actionable insights on integrated decision-making, data sharing, and more.

Register here 👉 us02web.zoom.us/webinar/regi...
April 14, 2025 at 2:53 PM
💡 Which brands are growing at the fastest pace—and what does this say about the industry's direction? Join us for this exclusive discussion exploring the brands reshaping the market and what their success signals for R&D, drug launches, and strategic planning. us02web.zoom.us/webinar/regi...
April 10, 2025 at 2:54 PM
Cross-functional collaboration is the key to driving efficiency, innovation, and impact in the #pharm industry. Join this discussion with experts from UCB, BMS, and Astellas on how to enhance communication, align teams, and optimize processes for success.

🔗 us02web.zoom.us/webinar/regi...
April 1, 2025 at 3:42 PM
Which brands are growing fastest—and what does this mean for industry trends? Join us to explore:

💊 Key drug performance
🏥 Franchise impact by disease area
📊 R&D benchmarking insights

Register here 👉 us02web.zoom.us/webinar/regi...
March 24, 2025 at 2:59 PM
Join us as industry experts explore strategies to break down silos and align diverse teams in the pharma industry. Gain practical insights for optimising processes, fostering innovation, and accelerating drug development and commercialisation. us02web.zoom.us/webinar/regi...
March 18, 2025 at 6:42 PM
🚀 #Precisionmedicine is advancing, but which tools are making the biggest impact? FirstWord is polling #physicians to get a clearer picture of the precision medicine landscape and identify barriers and boosters. Learn more: firstwordhealthtech.com/story/5940597
March 10, 2025 at 2:55 PM
This week's top #digitalhealth stories: firstwordhealthtech.com/story/5940280

Trump-backed Bhattacharya gets grilled; China’s ire hits Illumina; Novo Nordisk FORGEs new pact; and more

#AI #artificialintelligence #biotechnology #diagnostics #digitalhealth #healthIT #healthtech #pharmatech
March 7, 2025 at 4:29 PM
This week's top #pharma: firstwordpharma.com/story/5940455

Previewing a rash of readouts at #AAD, Senate scrutinizes Trump #healthcare picks, AbbVie enters #obesity arena…and more

#biotechnology #clinicalresearch #clinicaltrials #dermatology #drugdevelopment #patientaccess #pharmaceuticals
March 7, 2025 at 4:26 PM
Are doctors on board with AI's vision for cancer detection? #AI is transforming #cancerdetection by enhancing image analysis, improving accuracy, and even personalizing treatment plans. But how widely is it being adopted in practice? Learn more here: firstwordpharma.com/story/5939385
March 5, 2025 at 2:54 PM
🚨 NEW REPORT 🚨 KOL Insight: Migraine

Explore insights from #KOLs on the evolving landscape of #migraine therapies, focusing on anti-CGRP treatments, oral gepants, and future treatment pathways. Learn more: firstwordreports.com/story/5924637

#neurology #pharmaceuticals
March 4, 2025 at 4:24 PM
🚨 NEW REPORT 🚨 KOL Insight: Alzheimer's Disease

Explore insights from key opinion leaders on #Alzheimers therapies, highlighting Leqembi and Kisunla's promise, challenges, and future treatment pathways. Learn more: firstwordreports.com/story/5924642

#KOLs #neurology #pharmaceuticals
February 27, 2025 at 3:23 PM
🚨 TOMORROW: Precision Medicine 2025 🚨
Which #AI, #pharmacogenomics, and #digitaltools are driving real-world #precisionmedicine adoption? Experts from Pacific Biosciences, PrecisionLife & FirstWord break it down.
us02web.zoom.us/webinar/regi...

Sponsored by Answers in CME
February 25, 2025 at 2:43 PM
Collaboration is key to empowering a brighter future in #raredisease. Learn more from Takeda firstwordpharma.com/fostering-tr...

#collaboration #healthcare #pharmaceuticals #rarediseases
February 24, 2025 at 4:26 PM
#Precisionmedicine is evolving—are you keeping up? Join this exclusive discussion examining technologies driving real impact, where opportunities lie for #pharma, & leveraging these innovations for a competitive edge. Register now: us02web.zoom.us/webinar/regi...

Sponsored by AnswersinCME
February 13, 2025 at 2:22 PM